Australian Institute of Health and Welfare (2021) Alcohol and other drug treatment services in Australia annual report, AIHW, Australian Government, accessed 26 May 2022.
Australian Institute of Health and Welfare. (2021). Alcohol and other drug treatment services in Australia annual report. Retrieved from https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Alcohol and other drug treatment services in Australia annual report. Australian Institute of Health and Welfare, 16 July 2021, https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia annual report [Internet]. Canberra: Australian Institute of Health and Welfare, 2021 [cited 2022 May. 26]. Available from: https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Australian Institute of Health and Welfare (AIHW) 2021, Alcohol and other drug treatment services in Australia annual report, viewed 26 May 2022, https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Get citations as an Endnote file:
PDF | 9.8Mb
There are several medications (pharmacotherapies) used to treat problems with alcohol, tobacco and other drugs. These pharmacotherapies can be prescribed for a short, medium or long-term duration, depending on the person’s goals. Pharmacotherapies work in different ways. Some work by reducing cravings, others by providing an aversive (negative) reaction when used in combination with a substance. Other types of pharmacotherapy prevent withdrawal, reduce cravings and block the reinforcing effects of additional drug use. Pharmacotherapies are prescribed by approved prescribers and dispensed either through a community pharmacy or a specialist clinic (Department of Health 2019). Pharmacotherapy programs are available for a range of drugs, including alcohol and opioids. Where pharmacotherapy is used for withdrawal, it is also included in the ‘withdrawal’ category.
Only episodes where pharmacotherapy was either an additional treatment, or where it was the main treatment with an additional treatment provided, are included in the AODTS NMDS. Episodes where pharmacotherapy was the main treatment only and no additional treatment was provided are excluded. Pharmacotherapy is only available to clients receiving treatment for their own drug use. As most pharmacotherapy services are outside the scope of the AODTS NMDS, the data presented here are a substantial under‑representation. More information on opioid pharmacotherapy in Australia is available from the AIHW’s National Opioid Pharmacotherapy Statistics. The latest data indicate that on a snapshot day in 2020, over 53,300 clients received pharmacotherapy for opioid dependence, as reported in the National Opioid Pharmacotherapy Statistics Annual Data report (NOPSAD) (AIHW 2020).
For services that were in scope of the AODTS NMDS in 2019–20:
In 2019–20, for clients whose main treatment was pharmacotherapy:
For treatment episodes involving pharmacotherapy for a client’s own alcohol or drug use:
See reference list
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.